146 related articles for article (PubMed ID: 15499606)
1. Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients.
Schips L; Lipsky K; Zigeuner R; Gidaro S; Salfellner M; Rehak P; Pummer K; Hubmer G
J Surg Oncol; 2004 Nov; 88(2):57-61; discussion 61-2. PubMed ID: 15499606
[TBL] [Abstract][Full Text] [Related]
2. Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Yamasaki T; Kamba T; Kamoto T; Ogawa O
Urology; 2007 Jul; 70(1):50-4. PubMed ID: 17656207
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of body mass index in Korean patients with renal cell carcinoma.
Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879
[TBL] [Abstract][Full Text] [Related]
4. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
[TBL] [Abstract][Full Text] [Related]
5. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
[TBL] [Abstract][Full Text] [Related]
6. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.
Donat SM; Salzhauer EW; Mitra N; Yanke BV; Snyder ME; Russo P
J Urol; 2006 Jan; 175(1):46-52. PubMed ID: 16406867
[TBL] [Abstract][Full Text] [Related]
7. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
9. Is there any survival advantage of obesity in Southern European haemodialysis patients?
Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
[TBL] [Abstract][Full Text] [Related]
10. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
[TBL] [Abstract][Full Text] [Related]
11. Impact of body mass index in Korean patients with renal cell carcinoma.
Sung HH; Jeon SS; Park SY; Jeong BC; Seo SI; Lee HM; Choi HY
Cancer Causes Control; 2012 Mar; 23(3):505-11. PubMed ID: 22350955
[TBL] [Abstract][Full Text] [Related]
12. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
14. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma.
Brookman-May S; Kendel F; Hoschke B; Wieland WF; Burger M; Rössler W; May M
Scand J Urol Nephrol; 2011 Feb; 45(1):5-14. PubMed ID: 20846080
[TBL] [Abstract][Full Text] [Related]
15. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
16. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.
Escudier B; Choueiri TK; Oudard S; Szczylik C; Négrier S; Ravaud A; Chevreau C; Venner P; Champagne P; Croteau D; Dupont E; Hariton C; Bukowski RM
J Urol; 2007 Nov; 178(5):1901-5. PubMed ID: 17868728
[TBL] [Abstract][Full Text] [Related]
20. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
Ku JH; Moon KC; Kwak C; Kim HH
Urology; 2009 Aug; 74(2):359-63. PubMed ID: 19501879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
